Real-world response assessment of immune checkpoint inhibition: comparing iRECIST and RECIST 1.1 in melanoma and non-small cell lung cancer patients - Top-Institutions - MDSpire

Real-world response assessment of immune checkpoint inhibition: comparing iRECIST and RECIST 1.1 in melanoma and non-small cell lung cancer patients

  • By

  • Christian Nelles

  • Moritz Gräf

  • Pascale Bernard

  • Thorsten Persigehl

  • Nils Große Hokamp

  • David Zopfs

  • David Maintz

  • Nicole Kreuzberg

  • Jürgen Wolf

  • Paul J. Bröckelmann

  • Simon Lennartz

  • September 18, 2024

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Medical Oncology
    • Radiology
    • Immunotherapy Research

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Radiology
    • Cancer Immunotherapy

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Radiology
    • Translational Cancer Research

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Radiology
    • Immunotherapy

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Medical Oncology
    • Radiology
    • Cancer Immunotherapy

Original Source(s)

Real-world response assessment of immune checkpoint inhibition: comparing iRECIST and RECIST 1.1 in melanoma and non-small cell lung cancer patients

  • by Christian Nelles, Moritz Gräf, Pascale Bernard, Thorsten Persigehl, Nils Große Hokamp, David Zopfs, David Maintz, Nicole Kreuzberg, Jürgen Wolf, Paul J. Bröckelmann, Simon Lennartz

  • September 18, 2024

Related Content

Can AI Clarify Lung Screening?

Study assesses comprehension of large language model-generated lung screening summaries

CT-Based Assessment of Malignancy Risk in Part-Solid Pulmonary Nodules Utilizing Vascular Distortion and Interruption Analysis

Case Report: Atypical pattern of pathologic response in cutaneous transdifferentiated melanoma with rhabdomyoblastic differentiation following neoadjuvant therapy